These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9733142)

  • 1. Detection of human glandular kallikrein, hK2, as its precursor form and in complex with protease inhibitors in prostate carcinoma serum.
    Grauer LS; Finlay JA; Mikolajczyk SD; Pusateri KD; Wolfert RL
    J Androl; 1998; 19(4):407-11. PubMed ID: 9733142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma.
    Recker F; Kwiatkowski MK; Piironen T; Pettersson K; Lümmen G; Wernli M; Wiefelspütz J; Graber SF; Goepel M; Huber A; Tscholl R
    Cancer; 1998 Dec; 83(12):2540-7. PubMed ID: 9874461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of human glandular kallikrein, hK2, in mammalian cells.
    Kumar A; Goel AS; Hill TM; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Saedi MS
    Cancer Res; 1996 Dec; 56(23):5397-402. PubMed ID: 8968092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. alpha2-macroglobulin and C1-inactivator are plasma inhibitors of human glandular kallikrein.
    Heeb MJ; España F
    Blood Cells Mol Dis; 1998 Dec; 24(4):412-9. PubMed ID: 9851894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of human glandular kallikrein hK2 from LNCaP cells.
    Grauer LS; Charlesworth MC; Saedi MS; Finlay JA; Liu RS; Kuus-Reichel K; Young CY; Tindall DJ
    J Androl; 1996; 17(4):353-9. PubMed ID: 8889697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of prostate-specific antigen and human glandular kallikrein 2 in different body fluids.
    Lövgren J; Valtonen-André C; Marsal K; Lilja H; Lundwall A
    J Androl; 1999; 20(3):348-55. PubMed ID: 10386814
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate-specific human kallikrein (hK2) as a novel marker for prostate cancer.
    Young CY; Seay T; Hogen K; Charlesworth MC; Roche PC; Klee GG; Tindall DJ
    Prostate Suppl; 1996; 7():17-24. PubMed ID: 8950360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Similar rates of exponential decrease in serum concentrations of free prostate-specific antigen (PSA), PSA complexed to alpha-1-antichymotrypsin, and human glandular kallikrein 2 (hK2) in prostate cancer patients treated with GnRH-analogues.
    Björk T; Schalken J; Wittjes W; Ljungberg B; Lilja H
    Prostate; 2001 Apr; 47(1):14-20. PubMed ID: 11304725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen.
    Black MH; Magklara A; Obiezu CV; Melegos DN; Diamandis EP
    Clin Chem; 1999 Jun; 45(6 Pt 1):790-9. PubMed ID: 10351987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.
    Becker C; Piironen T; Pettersson K; Björk T; Wojno KJ; Oesterling JE; Lilja H
    J Urol; 2000 Jan; 163(1):311-6. PubMed ID: 10604382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-reactivity of ten anti-prostate-specific antigen monoclonal antibodies with human glandular kallikrein.
    Corey E; Buhler KR; Vessella RL
    Urology; 1997 Oct; 50(4):567-71; discussion 571-2. PubMed ID: 9338733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity.
    Finlay JA; Evans CL; Day JR; Payne JK; Mikolajczyk SD; Millar LS; Kuus-Reichel K; Wolfert RL; Rittenhouse HG
    Urology; 1998 May; 51(5):804-9. PubMed ID: 9610595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generation of monoclonal antibodies specific for human kallikrein 2 (hK2) using hK2-expressing tumors.
    Fisher TL; Nocera M; Willis RA; Turner MJ; Abdul Alim CS; Brown DM; Bourne PA; di Sant'Agnese PA; Messing EM; Lord EM; Frelinger JG
    Prostate; 2002 May; 51(3):153-65. PubMed ID: 11967950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D.
    Hsieh ML; Charlesworth MC; Goodmanson M; Zhang S; Seay T; Klee GG; Tindall DJ; Young CY
    Cancer Res; 1997 Jul; 57(13):2651-6. PubMed ID: 9205072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kininogenase activity of prostate-derived human glandular kallikrein (hK2) purified from seminal fluid.
    Charlesworth MC; Young CY; Miller VM; Tindall DJ
    J Androl; 1999; 20(2):220-9. PubMed ID: 10232657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The value of (-7, -5)pro-prostate-specific antigen and human kallikrein-2 as serum markers for grading prostate cancer.
    Bangma CH; Wildhagen MF; Yurdakul G; Schröder FH; Blijenberg BG
    BJU Int; 2004 Apr; 93(6):720-4. PubMed ID: 15049979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum human glandular kallikrein (hK2) and insulin-like growth factor 1 (IGF-1) improve the discrimination between prostate cancer and benign prostatic hyperplasia in combination with total and %free PSA.
    Scorilas A; Plebani M; Mazza S; Basso D; Soosaipillai AR; Katsaros N; Pagano F; Diamandis EP
    Prostate; 2003 Feb; 54(3):220-9. PubMed ID: 12518327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large-scale propagation of recombinant adherent cells that secrete a stable form of human glandular kallikrein, hK2.
    Kumar A; Goel AS; Payne JK; Evans C; Mikolajczyk SD; Kuus-Reichel K; Saedi MS
    Protein Expr Purif; 1999 Feb; 15(1):62-8. PubMed ID: 10024471
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of a prostate-specific protein, human glandular kallikrein (hK2), in sera of patients with elevated prostate-specific antigen levels.
    Charlesworth MC; Young CY; Klee GG; Saedi MS; Mikolajczyk SD; Finlay JA; Tindall DJ
    Urology; 1997 Mar; 49(3):487-93. PubMed ID: 9123724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells.
    Väisänen V; Lövgren J; Hellman J; Piironen T; Lilja H; Pettersson K
    Prostate Cancer Prostatic Dis; 1999 Mar; 2(2):91-97. PubMed ID: 12496845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.